Independent Director 2025 Annual Performance Report
Guangdong Zhongsheng Pharmaceutical Co., Ltd. Independent Director 2025 Annual Performance Report
To all shareholders and shareholder representatives:
As an independent director of Guangdong Zhongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company" or "Zhongsheng Pharma"), in accordance with the "Company Law," "Administrative Measures for Independent Directors of Listed Companies," and other relevant laws, regulations, and the "Articles of Association" and "Work System for Independent Directors," I have faithfully and diligently performed my duties, fully leveraging the role of an independent director to safeguard the overall interests of the Company and the legitimate rights and interests of all shareholders, especially small and medium shareholders.
Herein is a report on my performance of independent director duties in 2025:
I. Basic Information
(I) Work Experience, Professional Background, and Concurrent Positions
I am Tao Jianhong, with a Ph.D. from Sun Yat-sen University. I previously served as Deputy Director of the Guangzhou Pharmaceutical Procurement and Supply Station of China National Pharmaceutical Corporation, Deputy Director of the Southern Pharmaceutical Economic Research Institute of the State Drug Administration, and Independent Director of Yipinhong Pharmaceutical Co., Ltd., Kexing Pharmaceutical Co., Ltd., and Peking University Medical Department Pharmaceutical Co., Ltd.
I am currently the Vice President of the China Pharmaceutical Commerce Association. I concurrently serve as an Independent Director of Guangzhou Xiangxue Pharmaceutical Co., Ltd. and Guangxi Liuyao Group Co., Ltd. I was elected as an Independent Director of the Ninth Board of Directors of Zhongsheng Pharma from December 29, 2025.
I meet the qualification requirements for independent directors of listed companies as stipulated by relevant laws, regulations, and regulatory rules, and have been filed and reviewed by the Shenzhen Stock Exchange.
(II) No Circumstances Affecting Independence
As an independent director of Zhongsheng Pharma, I possess the independence required by the "Administrative Measures for Independent Directors of Listed Companies," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Normative Operation of Main Board Listed Companies," the "Articles of Association," and the "Work System for Independent Directors." I have conducted an independence self-assessment in accordance with regulatory rules and confirmed that I meet the applicable regulatory requirements for serving as an independent director. I have submitted the self-assessment results to the Board of Directors. The Board of Directors has evaluated my independence and found no circumstances that could affect my ability to make independent and objective judgments as an independent director. There are no relationships between me and the Company or its controlling shareholders that could hinder independent and objective judgment. I perform my duties independently and am not influenced by the Company's controlling shareholders or any other entities or individuals with related interests, and there are no circumstances affecting the independence of independent directors.
II. Annual Performance Overview
(I) Meeting Attendance
During my tenure in 2025, I have upheld an diligent and responsible work attitude, attending board meetings on time and participating in board decision-making, expressing clear opinions on matters discussed. There were no instances of missing two consecutive meetings without personal attendance or entrusting other independent directors to attend on my behalf.